JOMPAC
Journal of Medicine and Palliative Care

Journal of Medicine and Palliative Care (JOMPAC) is an open access scientific journal with independent, unbiased, and double-blind review under international guidelines. The purpose of JOMPAC is to contribute to the literature by publishing articles on health sciences and medicine.

eISSN: 2717-7505
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Submit Manuscript

Index
Original Article
Distribution of yeasts in fungal urinary tract infections from a tertiary care hospital
Abstract
Aims: Urinary tract infections caused by fungi in critically ill patients steadily increasing in recent years. Fungiuria is a marker of contamination, colonization, or infection in the lower or upper urinary tract. As urinary catheters especially long-term usage was the most important risk factor for fungiuria. The identification of yeast isolates at the species level is crucial for the appropriate management of infection. We conducted this study to describe the epidemiological features of fungiuria in patients.
Methods: The yeast species were identified by using conventional methods and automated systems. Demographic data were recorded from the electronic medical records.
Results: Candida albicans, were predominant compared to non-albicans Candida species and yeast-like fungi. Among non-albicans Candida, the most common species were Candida tropicalis followed by Candida glabrata complex. Fungiuria was more common in females than in males. Underlying conditions were present in patients the most common risk factors were antibiotic therapy before the detection of yeasts and using a urinary catheter.
Conclusion: Epidemiological data and antimicrobial therapy play an important role in the treatment of urinary tract infections. For this reason, the identification of fungi at the species level is critical to assist the decision on antifungal therapy in complex cases. In all patients with fungal growth in urine culture, the underlying risk factors should be evaluated first. Depending on the correction of risk factors, fungiuria may resolve spontaneously. This is seen as the best approach both to reduce treatment costs and to prevent resistance to antifungals.

Keywords : Fungiuria, candiduria, urinary tract infection, urinary catheter

Download Article


1. Dias V. Candida species in the urinary tract: Is it a fungalinfection or not? Future Microbiol. 2020;15(2):81-83. doi:10.2217/fmb-2019-0262
2. Yadav RK, Singh G, Kiran KS, et al. A study on candiduria inneonates and infants from a tertiary care center, North India.Indian J Med Microbiol. 2023;42(June 2022):25-29. doi:10.1016/j.ijmmb.2022.12.014
3. Gharaghani M, Taghipour S, Halvaeezadeh M, MahmoudabadiAZ. Candiduria; a review article with specific data from Iran.Turkish J Urol. 2018;44(6):445-452. doi:10.5152/tud.2018.54069
4. Malhotra S. Occurrence of Candiduria in Paediatric Patients andits Antifungal Susceptibility in a Tertiary Care Centre. J Infect DisMed. 2017;2(1):2-5.
5. He Z, Su C, Bi Y, Cheng Y, Lei D, Wang F. Evaluation of a novellaboratory candiduria screening protocol in the intensive careunit. Infect Drug Resist. 2021;14:489-496. doi:10.2147/IDR.S289885
6. Odabasi Z, Mert A. Candida urinary tract infections in adults.World J Urol. 2020;38(11):2699-2707. doi:10.1007/s00345-019-02991-5
7. Behzadi P, Behzadi E, Ranjbar R. Urinary tract infectionsand Candida albicans. Cent Eur J Urol. 2015;68(1):96-101.doi:10.5173/ceju.2015.01.474
8. He Z, Huo X, Lei D, Zhao H, Jia K, Wang F. Management ofcandiduria in hospitalized patients: a single-center study on theimplementation of IDSA guidelines and factors affecting clinicaldecisions. Eur J Clin Microbiol Infect Dis. 2021;40(1):59-65.doi:10.1007/s10096-020-03999-1
9. Tan X, Baugh K, Bulman ZP, Wenzler E. Review of the currentmanagement of urinary tract infections due to fluconazole-resistant and non-albicans Candida species. Curr Fungal InfectRep. 2020;14(3):268-278. doi:10.1007/s12281-020-00388-1
10. Kobayashi CCBA, De Fátima Lisboa Fernandes O, MirandaKC, De Sousa ED, Do Rosário Rodrigues Silva M. Candiduriain hospital patients: A study prospective. Mycopathologia.2004;158(1):49-52. doi:10.1023/B:MYCO.0000038436.51918.d9
11. Chaari A, Munir A, Sharaf A, Khairy A, Kauts V, Erdem H.Predictive factors and prognostic value of candiduria in critically-ill patients with solid and hematological malignancies. J MedMycol. 2023;33(1):101353. doi:10.1016/j.mycmed.2022.101353
12. Alfouzan WA, Dhar R. Candiduria: Evidence-based approach tomanagement, are we there yet? J Mycol Med. 2017;27(3):293-302.doi:10.1016/j.mycmed.2017.04.005
13. Hollenbach E. To treat or not to treat - Critically ill patients withcandiduria. Mycoses. 2008;51(SUPPL.2):12-24. doi:10.1111/j.1439-0507.2008.01570.x
14. Shirvani F, Fattahi M. Molecular identification of Candidaspecies isolated from candiduria and its risk factors in neonatesand children. Curr Med Mycol. 2021;17(3):9-12. doi:10.18502/CMM.7.3.7799
15. Kauffman CA. Diagnosis and management of fungal urinarytract infection. Infect Dis Clin North Am. 2014;28(1):61-74.doi:10.1016/j.idc.2013.09.004
16. Fisher JF, Kavanagh K, Sobel JD, Kauffman CA, Newman CA.Candida urinary tract infection: Pathogenesis. Clin Infect Dis.2011;52(SUPPL. 6):437-451. doi:10.1093/cid/cir110
17. He Z, Liu Y, Wang T, Cheng Y, Chen J, Wang F. Candiduria inhospitalized patients: An investigation with the Sysmex UF-1000iurine analyzer. PeerJ. 2019;2019(5). doi:10.7717/peerj.6935
18. Poloni JAT, Rotta LN. Urine sediment findings and the immuneresponse to pathologies in fungal urinary tract infectionscaused by Candida spp. J Fungi. 2020;6(4):1-12. doi:10.3390/jof6040245
19. Francisco EC, de Almeida Junior JN, de Queiroz Telles F, etal. Species distribution and antifungal susceptibility of 358Trichosporon clinical isolates collected in 24 medical centres.Clin Microbiol Infect. 2019;25(7):909.e1-909.e5. doi:10.1016/j.cmi.2019.03.026
20. Gajdács M, Dóczi I, Ábrók M, Lázár A, Burián K. Epidemiologyof candiduria and Candida urinary tract infections in inpatientsand outpatients: Results from a 10-year retrospective survey. CentEur J Urol. 2019;72(2):209-214. doi:10.5173/ceju.2019.1909
21. Gharaghani M, Rezaei-Matehkolaei A, Hardani AK,Mahmoudabadi AZ. Genetic analysis of Candida glabrata fromcandiduric patients using microsatellite length polymorphism,antifungal susceptibility, and enzymatic profiles. Jundishapur JMicrobiol. 2021;14(1):1-8. doi:10.5812/jjm.113716
22. Kauffman CA, Fisher JF, Sobel JD, Newman CA. Candida urinarytract infections - Diagnosis. Clin Infect Dis. 2011;52(SUPPL. 6).doi:10.1093/cid/cir111
23. Fulton MA, Wallace B, Akins R, Teresa L. A Win for PatientSafety: Collaboration to Curb Catheter-Associated Urinary TractInfections (CAUTIs) due to Candida species. Am J Infect Control.2015;43(6):S47-S48. doi:10.1016/j.ajic.2015.04.120
24. Rkieh L, El Nekidy WS, Alsoud LO, et al. Outcomes ofcaspofungin use in the treatment of Candida-related urinarytract infections, a case series. IDCases. 2022;28(May):e01510.doi:10.1016/j.idcr.2022.e01510
25. Pramodhini S, Srirangaraj S, Easow JM. Candiduria—studyof virulence factors and its antifungal susceptibility pattern intertiary care hospital. J Lab Physicians. 2021;13(03):231-237.doi:10.1055/s-0041-1730880
26. Demir C, Metin S. Microorganisms grown in urine culturesand antimicrobial resistance patterns: A randomisedretrospective analysis from a tertiary hospital. J Infect Dev Ctries.2023;17(3):337-344. doi:10.3855/jidc.17483
27. García-Agudo L, Rodríguez-Iglesias M, Carranza-GonzálezR. Nosocomial Candiduria in the Elderly: MicrobiologicalDiagnosis. Mycopathologia. 2018;183(3):591-596. doi:10.1007/s11046-017-0232-7
28. Toka Özer T, Durmaz S, Yula E. Antifungal susceptibilities ofCandida species isolated from urine culture. J Infect Chemother.2016;22(9):629-632. doi:10.1016/j.jiac.2016.06.012
29. Paul N, Mathai E, Abraham OC, Michael JS, Mathai D. Factorsassociated with candiduria and related mortality. J Infect.2007;55(5):450-455. doi:10.1016/j.jinf.2007.06.010
30. Singla N, Gulati N, Kaistha N, Chander J. Candida colonizationin urine samples of ICU patients: determination of etiology,antifungal susceptibility testing and evaluation of associatedrisk factors. Mycopathologia. 2012;174(2):149-155. doi:10.1007/s11046-011-9514-7
31. Esmailzadeh A, Zarrinfar H, Fata AM, Sen T. High prevalence ofcandiduria due to non-albicans Candida species among diabeticpatients: A matter of concern? J Clin Lab Anal. 2018;32(4):1-5.doi:10.1002/jcla.22343
32. McMorris TE, Smith WJ, Kupiec K, et al. Micafungin therapyfor symptomatic candiduria in hospitalized patients: A reviewof 14 cases. Infect Dis Clin Pract. 2017;25(2):88-93. doi:10.1097/IPC.0000000000000461
33. Bukhary ZA. Candiduria: a review of clinical significance andmanagement. Saudi J Kidney Dis Transpl. 2008;19(3):350-360.
34. Hosseini SS, Ghaemi E, Noroozi A, Niknejad F. Zinc oxidenanoparticles inhibition of initial adhesion and ALS1 and ALS3gene expression in Candida albicans strains from urinary tractinfections. Mycopathologia. 2019;0123456789. doi:10.1007/s11046-019-00327-w
35. De Sousa IA, Braoios A, Santos TG, De Lima JA, Da Costa RM.Candiduria in adults and children: Prevalence and antifungalsusceptibility in outpatient of Jataí-GO. J Bras Patol e Med Lab.2014;50(4):259-264. doi:10.5935/1676-2444.20140024
36. Ödemiş İ, İmre A. KatAter ilişkili üriner sistem enfeksiyonlarındamortalite ile ilişkili faktörlerin değerlendirilmesi, 5 yıllıkretrosepektif çalışma. Kahramanmaraş Sütçü İmam ÜniversitesiTıp Fakültesi Derg. 2022:0-3. doi:10.17517/ksutfd.1146548
37. Korkmaz D, Demirtürk N, Keşli R, Konya P. Hospitalizekandidürili hastalarda risk faktörlerinin araştırılması. ActaMedica Alanya. 2019;3(1):72-77. doi:10.30565/medalanya.519111
Article available in :
Volume 4, Issue 4, 2023
Page : 296-301
https://doi.org/10.47582/jompac.1325399
Article Information
Received : 11 Tem 2023
Accepted : 03 Ağu 2023
Published : 30 Ağu 2023
Corresponding Author :

Rabiya Altınbaş: Department of Medical Microbiology, Gaziantep Dr. Ersin Arslan Training and Research Hospital, Gaziantep, Turkey

[email protected]
Citation : Altınbaş R, Bildirici Y. Distribution of yeasts in fungal urinary tract infections from a tertiary care hospital. J Med Palliat Care. 2023;4(4):296-301.

Read: 112
Cited: 0
Download : 97
_Footer